合成路线1
该中间体在本合成路线中的序号:
(II) The condensation of 3-(tert butoxycarbonyl amino)-1-hydroxy-4-methylazetidin-2-one (I) with chloroacetic acid (II) by means of K2CO3 gives 2-(3-(tert butoxycarbonylamino)-4-methyl-2-oxoazetidin-1-yloxy]acetic acid (III), which is deprotected with trifluoroacetic acid yielding 2-(3-amino 4-methyl-2-oxoazetidin-1-yloxy)acetic acid (IV). Finally, this compound is condensed with 2-(2-amino-thiazol-4-yl)-2-(methoxyimino)acetyl chloride (V) by means of Na2CO3.
【1】
Breuer, H.; et al.; [(2-Oxo-1-azetidinyl)oxy]acetic acids: A new class of synthetic monobactams. J Antibiot 1985, 38, 6, 813.
|
【2】
Miller, M.J.; Woulfe, S.R.; Synthesis and biological activity of substituted [(3(S)-(acylamino)-2-oxo-1-azetidinyl]oxy]acetic acids. A new class of heteroatom-activated beta-lactam antibiotics. J Med Chem 1985, 28, 10, 1447.
|
【3】
Breuer, H.; Straub, H.; Treuner, U.D. (Von Heyden); beta-Lactam derivs.. DE 3328047; GB 2125794 .
|
【4】
Castaner, J.; Prous, J.; Oximonam sodium. Drugs Fut 1986, 11, 9, 759.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24312 |
butyl (2S,3S)-1-hydroxy-2-methyl-4-oxoazetidinylcarbamate
|
|
C9H16N2O4 |
详情 |
详情
|
(II) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(III) |
24314 |
2-([(2S,3S)-3-[(butoxycarbonyl)amino]-2-methyl-4-oxoazetidinyl]oxy)acetic acid
|
|
C11H18N2O6 |
详情 |
详情
|
(IV) |
24315 |
2-[[(2S,3S)-3-amino-2-methyl-4-oxoazetidinyl]oxy]acetic acid
|
|
C6H10N2O4 |
详情 |
详情
|
(V) |
24316 |
2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl chloride
|
|
C6H6ClN3O2S |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(XXII) The reaction of 4-phenyl-1-butene (XX) with hypophosphorous acid gives 4-phenylbutylphosphinic acid (XXI), which is condensed with chloroacetic acid (XXII) yielding 2-[hydroxy(4-phenylbutyl)phosphoryl]acetic acid (XXIII). The esterifica-tion of (XXII) with benzyl alcohol affords the benzyl acetate (XXIV), which is esterified at the OH group of the phosphinic acid with 2-methyl-1-(propionyloxy)propyl chloride (XXV) giving the completely esterified derivative (XXVI). The debenzylation of (XXVI) with H2 over Pd/C yields the acetic acid derivative (XXVII), which is submitted to optical resolution affording the desired (S)-isomer (XXVIII). Finally, this compound is condensed with the desired intermediate trans-4-cyclohexyl-L-proline (XI) by means of CDI and NaOH.
【1】
Anderson, N.G.; et al.; Generation and fate of regioisomeric side-chain impurities in the preparation of fosinopril sodium. Org Process Res Dev 1997, 1, 4, 315.
|
【2】
Anderson, N.G.; et al.; Process development for the preparation of a monopril intermediate by a trimethylsilyl-modified arbuzov reaction. Org Process Res Dev 1997, 1, 3, 211.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
38567 |
(2S,4S)-4-cyclohexyl-2-pyrrolidinecarboxylic acid
|
|
C11H19NO2 |
详情 |
详情
|
(XX) |
20933 |
1-(3-butenyl)benzene
|
768-56-9 |
C10H12 |
详情 | 详情
|
(XXI) |
20932 |
4-phenylbutylphosphinic acid
|
|
C10H15O2P |
详情 |
详情
|
(XXII) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(XXIII) |
38575 |
2-[hydroxy(4-phenylbutyl)phosphoryl]acetic acid
|
|
C12H17O4P |
详情 |
详情
|
(XXIV) |
38576 |
2-(benzyloxy)-2-oxoethyl(4-phenylbutyl)phosphinic acid
|
|
C19H23O4P |
详情 |
详情
|
(XXV) |
38577 |
1-chloro-2-methylpropyl propionate
|
|
C7H13ClO2 |
详情 |
详情
|
(XXVI) |
38578 |
1-[[[2-(benzyloxy)-2-oxoethyl](4-phenylbutyl)phosphoryl]oxy]-2-methylpropyl propionate
|
|
C26H35O6P |
详情 |
详情
|
(XXVII) |
38579 |
2-[[2-methyl-1-(propionyloxy)propoxy](4-phenylbutyl)phosphoryl]acetic acid
|
|
C19H29O6P |
详情 |
详情
|
(XXVIII) |
38580 |
2-[[[(1S)-2-methyl-1-(propionyloxy)propyl]oxy](4-phenylbutyl)phosphoryl]acetic acid
|
|
C19H29O6P |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) The two enantiomers of amlodipine have been obtained as follows:
The reaction of 2-azidoethanol (I) with chloroacetic acid (II) by means of NaH in THF gives 2-(2-azidoethoxy)acetic acid (III), which is condensed with Meldrum's acid (IV) and 3-hydroxypropionitrile (V) in dichloromethane to yield the 2-cyanoethyl acetoacetate (VI). The cyclization of (VI) with 2-chlorobenzaldehyde (VII) and methyl 3-aminocrotonate (VIII) in refluxing ethanol affords the dihydropyridine (IX), which is selectively hydrolyzed at the 2-cyanoethylester with NaOH to give the dihydropyridine monocarboxylic acid (X). The esterification of (X) with (S)-2-methoxy-2-phenylethanol (XI) by means of CDI in dichloromethane provides the ester (XII) as a diastereomeric mixture, which is separated by chromatography to furnish diastereomers (XXI A) and (XII B). The selective ethanolysis of (XII A) and (XII B) with sodium ethoxide in refluxing ethanol/diglyme gives enantiomers (+)-(XIII) and (-)-(XIII), which are finally reduced with H2 over Pd/CaCO3 in ethanol to afford the (-)- and (+)-isomers, respectively, of the target compound.
【1】
Arrowsmith, J.E.; et al.; Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents. J Med Chem 1986, 29, 9, 1696.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24111 |
2-azido-1-ethanol
|
|
C2H5N3O |
详情 |
详情
|
(II) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(III) |
48263 |
2-(2-azidoethoxy)acetic acid
|
|
C4H7N3O3 |
详情 |
详情
|
(IV) |
14738 |
Meldrum's acid; 2,2-dimethyl-1,3-dioxane-4,6-dione;Malonic acid cyclic isopropylidene ester |
2033-24-1 |
C6H8O4 |
详情 | 详情
|
(V) |
14029 |
Ethylene cyanohydrin; ECN; 3-Hydroxypropanenitrile
|
109-78-4 |
C3H5NO |
详情 | 详情
|
(VI) |
48264 |
2-cyanoethyl 4-(2-azidoethoxy)-3-oxobutanoate
|
|
C9H12N4O4 |
详情 |
详情
|
(VII) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(VIII) |
11372 |
Methyl (E)-3-amino-2-butenoate; Methyl 3-aminocrotonate
|
|
C5H9NO2 |
详情 |
详情
|
(IX) |
48265 |
3-(2-cyanoethyl) 5-methyl 2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C21H22ClN5O5 |
详情 |
详情
|
(X) |
48266 |
2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydro-3-pyridinecarboxylic acid
|
|
C18H19ClN4O5 |
详情 |
详情
|
(XI) |
48267 |
(2S)-2-methoxy-2-phenyl-1-ethanol
|
66051-01-2 |
C9H12O2 |
详情 | 详情
|
(XII) |
48268 |
3-[(2S)-2-methoxy-2-phenylethyl] 5-methyl 2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C27H29ClN4O6 |
详情 |
详情
|
(XIII) |
24115 |
3-ethyl 5-methyl 2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C20H23ClN4O5 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(VIII) Aceclofenac was prepared by selective hydrolysis of other labile ester precursors. Alkylation of diclofenac sodium (I) with tetrahydropyranyl chloroacetate (IX), prepared by protection of chloroacetic acid (VIII) with dihydropyran, furnished the tetrahydropyranyl ester of aceclofenac (X), which was then deprotected by treatment with HCl. Similarly, the preparation of aceclofenac was reported by acidic hydrolysis of the analogous tetrahydrofuranyl ester (XI).
【1】
Flores Ramos, R. (Almirall Prodesfarma, SA); Process for obtaining 2-[(2,6-dichlorophenyl)amino]phenylacetoxy acetic acid. ES 2046141 .
|
【2】
Zirngibl, L.; Gnehm, R. (Siegfried AG); Process for the preparation of a phenylacetic acid deriv.. CH 682747 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
56535 |
sodium 2-[2-(2,6-dichloroanilino)phenyl]acetate
|
|
C14H10Cl2NNaO2 |
详情 |
详情
|
(VIII) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(IX) |
56539 |
tetrahydro-2H-pyran-2-yl 2-chloroacetate
|
|
C7H11ClO3 |
详情 |
详情
|
(X) |
56540 |
2-oxo-2-(tetrahydro-2H-pyran-2-yloxy)ethyl 2-[2-(2,6-dichloroanilino)phenyl]acetate
|
|
C21H21Cl2NO5 |
详情 |
详情
|
(XI) |
56541 |
2-oxo-2-(tetrahydro-2-furanyloxy)ethyl 2-[2-(2,6-dichloroanilino)phenyl]acetate
|
|
C20H19Cl2NO5 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(A) This compound can be prepared in several different ways:
1) The reaction of benzhydryl bromide (I) with thiourea (II) in refluxing water gives diphenyl - methanethiol (III), which is condensed with chloroacetic acid (A) by means of NaOH in hot water yielding (benzhydrylthio)acetic acid (IV). The esterification of (IV) with ethanol and H2SO4 affords the corresponding ethyl ester (V), which is treated with hydroxylamine hydrochloride and KOH in methanol to give benzhydrylthioacetohydroxamic acid (VI). Finally, this compound is oxidized with H2O2 in acetic acid.
2) Compound (III) can also be obtained by reaction of benzhydrol (VII) with thiourea and aqueous 48% HBr at 100 C.
3) Compound (IV) can be oxidized with H2O2 in water to give benzhydrylsulfinylacetic acid (VIII), which is methylated with dimethyl sulfate and NaHCO3 in water to the corresponding methyl ester (IX). Finally, this compound is treated with hydroxylamine and NaOH in water
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(I) |
12079 |
Bromodiphenylmethane; 1-[Bromo(phenyl)methyl]benzene; Benzhydrylbromide
|
776-74-9 |
C13H11Br |
详情 | 详情
|
(II) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(III) |
32695 |
diphenylmethanethiol; benzhydrylhydrosulfide
|
|
C13H12S |
详情 |
详情
|
(IV) |
11848 |
2-(Benzhydrylsulfanyl)acetic acid
|
|
C15H14O2S |
详情 |
详情
|
(V) |
32696 |
ethyl 2-(benzhydrylsulfanyl)acetate
|
|
C17H18O2S |
详情 |
详情
|
(VI) |
32697 |
2-(benzhydrylsulfanyl)-N-hydroxyacetamide
|
63547-44-4 |
C15H15NO2S |
详情 | 详情
|
(VII) |
11845 |
Diphenylmethanol; Benzhydrol
|
91-01-0 |
C13H12O |
详情 | 详情
|
(VIII) |
11851 |
2-(Benzhydrylsulfinyl)acetic acid
|
|
C15H14O3S |
详情 |
详情
|
(IX) |
11852 |
methyl 2-(benzhydrylsulfinyl)acetate
|
|
C16H16O3S |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(A) (rac)-1,2-Diaminopropane is resolved using (-)-L-tartaric acid. The bitartrate salt is treated with HCl to give the dihydrochloride salt, (-)-S-1,2-diaminopropane dihydrochloride (I). (I) in water is added to a solution of chloroacetic acid and sodium hydroxide below 20 C, and allowed to stand at room temperature for 7 days. After concentration and filtration, the product is isolated by passing the filtrate down an ion exchange column and eluting with water. The portion of the eluate containing the bulk of the optical activity is concentrated by heating. Crystals of (+)-(S)-1,2-propylene dinitrilotetraacetic acid (II) are obtained by filtration. (II) is heated under nitrogen for 20 h at 165 C to give (+)-(S)-1,2-di(piperazine-2,6-dione)propane.
【1】
NS-2330 enters phase IIb in Alzheimer's disease. J Pharm Sci 1976, 65, 238-242.
|
【2】
Eastland, G.; ICRF-187. Drugs Fut 1987, 12, 11, 1017.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(I) |
27996 |
(1S)-2-amino-1-methylethylamine
|
|
C3H10N2 |
详情 |
详情
|
(II) |
27997 |
2-[[(1S)-2-[bis(carboxymethyl)amino]-1-methylethyl](carboxymethyl)amino]acetic acid
|
|
C11H18N2O8 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(III) This compound can be obtained by two related ways:
1) The condensation of benzhydrol (I) with chloroacetic acid (II) by means of thiourea (III) in concentrated hydrobromic acid at 95 C gives 2-(diphenylmethylthio)acetic acid (IV), which by reaction with SOCl2 in refluxing benzene is converted into the acid chloride (V). The reaction of (V) with ammonium hydroxide in water - methylene chloride affords 2-(diphenylmethylthio)acetamide (VI), which is finally oxidized with hydrogen peroxide.
2) Acid (IV) can also be oxidized with hydrogen peroxide to give 2-(diphenylmethylsulfinyl)acetic acid (VII), which is methylated with dimethylsulfate and NaHCO3 to the corresponding methyl ester (VIII). Finally, this compound is treated with ammonia in anhydrous methanol.
【1】
Lafon, L. (Laboratoires L. Lafon); Acetamide derivs. DE 2809625; FR 2385693; US 4177290 .
|
【2】
Prous, J.; Castaner, J.; MODAFINIL. Drugs Fut 1990, 15, 2, 130.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11845 |
Diphenylmethanol; Benzhydrol
|
91-01-0 |
C13H12O |
详情 | 详情
|
(II) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(III) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(IV) |
11848 |
2-(Benzhydrylsulfanyl)acetic acid
|
|
C15H14O2S |
详情 |
详情
|
(V) |
11849 |
2-(Benzhydrylsulfanyl)acetyl chloride
|
|
C15H13ClOS |
详情 |
详情
|
(VI) |
11850 |
2-(Benzhydrylsulfanyl)acetamide
|
|
C15H15NOS |
详情 |
详情
|
(VII) |
11851 |
2-(Benzhydrylsulfinyl)acetic acid
|
|
C15H14O3S |
详情 |
详情
|
(VIII) |
11852 |
methyl 2-(benzhydrylsulfinyl)acetate
|
|
C16H16O3S |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(IV) The chiral diamine (II) was obtained by resolution of racemic 1,2-diaminopropane (I) with D-tartaric acid. Condensation of diamine (II) with formaldehyde and NaCN produced the tetranitrile (III). Acidic hydrolysis of tetranitrile (III) produced tetraamide (VI). The cyclization of (VI) upon heating in phenol furnished the title bis-piperazinedione. The cyclization of tetraamide (VI) has also been reported using polyphosphoric acid or sodium (methylsulfinyl)methyde.
Alternatively, the synthesis of Dexrazoxane can be performed by by alkylation of diamine (II) with chloroacetic acid (IV) by means of NaOH in water to afford tetraacid (V), which is then subjected to cyclization in hot formamide.
【1】
Miller, W.D.; Process for preparing (S)(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione). EP 0284594 .
|
【2】
Tu, C.-Y.J.; Clark, G.W.; Borsotti, G.; Process for preparing bis(3,5-dioxopiperazinyl)alkanes or alkenes. EP 0330381 .
|
【3】
Creighton, A.M. (National Research Development Corp.); (3,5,3',5'-Tetraoxo)-1,2-dipiperazinoalkane cpds. and process for their preparation. DE 1910283; DE 1967027 .
|
【4】
Holthuis, J.J.M.; MacDonald, P.L.; Stradi, R.; Rossetto, P. (EuroCetus BV); Process for preparing (S)(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione). WO 9308172 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30691 |
1,2-propanediamine; 2-amino-1-methylethylamine
|
78-90-0 |
C3H10N2 |
详情 | 详情
|
(II) |
27996 |
(1S)-2-amino-1-methylethylamine
|
|
C3H10N2 |
详情 |
详情
|
(III) |
55629 |
2-[{(1S)-2-[bis(cyanomethyl)amino]-1-methylethyl}(cyanomethyl)amino]acetonitrile
|
|
C11H14N6 |
详情 |
详情
|
(IV) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(V) |
27997 |
2-[[(1S)-2-[bis(carboxymethyl)amino]-1-methylethyl](carboxymethyl)amino]acetic acid
|
|
C11H18N2O8 |
详情 |
详情
|
(VI) |
55630 |
2-((2-amino-2-oxoethyl){(1S)-2-[bis(2-amino-2-oxoethyl)amino]-1-methylethyl}amino)acetamide
|
|
C11H22N6O4 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
Proxodolol (V) was obtained as shown in Scheme 21696501a:
Monoalkylation of pyrocatechol with chloroacetic acid gives 2-hydroxyphenoxyacetic acid (I), which is cyclized on heating into 1,4-benzodioxan-2-one (II). Condensation of (II) with acetamidoxime, giving 2-methyl-5-(2-hydroxyphenoxymethyl)-1,2,4-oxadiazole (III), followed by alkylation with epichlorohydrin yields the corresponding diether (IV), which smoothly reacts with tert-BuNH2, and the amine (V) is converted into its hydrochloride by reaction with HCl.
【1】
Mashkovski, M.D.; Sokolov, S.D.; Vinogradova, S.M.; Yuzhakov, S.D.; Yermakova, V.N.; Proxodolol. Drugs Fut 1997, 22, 5, 499.
|
【2】
Sokolov, S.D.; Vinogradova, S.M.; Azarevich, O.G.; Berg, M.V.; Mashkovski, M.D.; Yuzhakov, S.D.; Morozov, A.V. (Center for Chemistry of Drugs); The hydrochlorides of derivs. of 5-phenoxymethyl-1,2, 4-oxadiaxole, possessing beta- and alpha-adrenoblocking activities. SU 1132505 . |
【3】
Sokolov, S.D.; Vinogradova, S.M.; Azarevich, O.G. (Center for Chemistry of Drugs); The method for producing of 5-(2-hydroxyphenoxymethyl)-1,2,4-oxadiazoles. SU 1139129 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
|
11599 |
o-Dihydroxybenzene; Catechol; Pyrocatechol
|
120-80-9 |
C6H6O2 |
详情 | 详情
|
|
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
|
64134 |
N'-hydroxyethanimidamide
|
|
C2H6N2O |
详情 |
详情
|
(I) |
16894 |
2-Hydroxyphenoxyacetic acid; o-Hydroxyphenoxyacetic acid; 2-(2-hydroxyphenoxy)acetic acid
|
6324-11-4 |
C8H8O4 |
详情 | 详情
|
(II) |
16895 |
1,4-BENZODIOXAN-2-ONE; 1,4-benzodioxin-2(3H)-one
|
4385-48-2 |
C8H6O3 |
详情 | 详情
|
(III) |
16896 |
2-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]phenol
|
|
C10H10N2O3 |
详情 |
详情
|
(IV) |
16897 |
2-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]phenyl 2-oxiranylmethyl ether; 3-methyl-5-[[2-(2-oxiranylmethoxy)phenoxy]methyl]-1,2,4-oxadiazole
|
|
C13H14N2O4 |
详情 |
详情
|
(V) |
16898 |
1-(tert-butylamino)-3-[2-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]phenoxy]-2-propanol hydrochloride
|
|
C17H26ClN3O4 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(XXII) Reaction of chloroacetic acid (XXII) with sodium ethoxide (XXIII) in ethanol gives 2-ethoxyacetic acid ethyl ester (XXIV), which is condensed with 4-methoxybenz-aldehyde (XXV) by means of t-BuOK in THF to yield 2-ethoxy-3-(4-methoxyphenyl)-2-propenoic acid ethyl ester (XXVI). Hydrolysis of ester (XXVI) with NaOH in hot ethanol/water affords the propenoic acid derivative (XXVII), which is reduced with H2 over Pd/C in ethanol to provide racemic 2-ethoxy-3-(4-methoxyphenyl)propionic acid (XXVIII). Optical resolution of mixture (XXVIII) is performed by salt formation with 1(S)-(1-naphthyl)ethylamine (XXIX) followed by crystallization to give the diastereomeric salt (XXX), which is treated with NaOH, followed by acidification with HCl to yield 2(S)-ethoxy-3-(4-methoxyphenyl)propionic acid (XXXI). Demethylation of compound (XXXI) by reaction with NaOH and octanethiol in NMP affords 2(S)-ethoxy-3-(4-hydroxyphenyl)propionic acid (XXXII), which is esterified with ethanol/HCl to provide the corresponding ethyl ester (XXXIII). Condensation of ester (XXXIII) with the bismesylate (II) by means of either K2CO3 in 2-butanone or Na2CO3 in acetone provides 2(S)-ethoxy-3-[4-[2-[4-(methanesulfonyloxy)-phenyl]ethoxy]phenyl]propionic acid ethyl ester (XXI), which is finally hydrolyzed with NaOH or LiOH in acetone/water.
【1】
McIntyre, J.A.; Castaner, J.; Bayes, M.; Tesaglitazar. Drugs Fut 2003, 28, 10, 959.
|
【2】
Ioannidis, P.; Ehrl, R.; MacKintosh, W. (AstraZeneca AB); Process for the preparation 3-aryl-2-hydroxypropionic acid deriv.. WO 0296865 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
50403 |
4-[2-[(methylsulfonyl)oxy]ethyl]phenyl methanesulfonate
|
|
C10H14O6S2 |
详情 |
详情
|
(XX) |
50418 |
ethyl (2S)-2-ethoxy-3-(4-hydroxyphenyl)propanoate
|
|
C13H18O4 |
详情 |
详情
|
(XXI) |
50419 |
ethyl (2S)-2-ethoxy-3-[4-([4-[(methylsulfonyl)oxy]phenethyl]oxy)phenyl]propanoate
|
|
C22H28O7S |
详情 |
详情
|
(XXII) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(XXIII) |
63048 |
sodium 1-ethanolate
|
|
C2H5NaO |
详情 |
详情
|
(XXIV) |
63049 |
ethyl 2-ethoxyacetate
|
|
C6H12O3 |
详情 |
详情
|
(XXV) |
27251 |
4-methoxybenzaldehyde; Anisicaldehyde; p-anisaldehyde
|
123-11-5 |
C8H8O2 |
详情 | 详情
|
(XXVI) |
63050 |
ethyl (E)-2-ethoxy-3-(4-methoxyphenyl)-2-propenoate
|
|
C14H18O4 |
详情 |
详情
|
(XXVII) |
63051 |
(E)-2-ethoxy-3-(4-methoxyphenyl)-2-propenoic acid
|
|
C12H14O4 |
详情 |
详情
|
(XXVIII) |
63052 |
2-ethoxy-3-(4-methoxyphenyl)propanoic acid
|
|
C12H16O4 |
详情 |
详情
|
(XXIX) |
17443 |
(1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine
|
3886-70-2 |
C12H13N |
详情 | 详情
|
(XXX) |
63053 |
(1S)-1-(1-naphthyl)-1-ethanaminium (2S)-2-ethoxy-3-(4-methoxyphenyl)propanoate
|
|
C24H29NO4 |
详情 |
详情
|
(XXXI) |
63054 |
(2S)-2-ethoxy-3-(4-methoxyphenyl)propanoic acid
|
|
C12H16O4 |
详情 |
详情
|
(XXXII) |
63055 |
(2S)-2-ethoxy-3-(4-hydroxyphenyl)propanoic acid
|
|
C11H14O4 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(XXXV) Finally, etoricoxib is obtained by several related ways:
Cyclization of ketosulfone (XXIV) with 2-chloromalondialdehyde (XXIX) or the aniline derivative (XXX) and ammonium acetate in hot propionic acid.
Cyclization of ketosulfone (XXIV) with aminoacrolein (XXXI) in the absence of ammonium acetate. Aminoacrolein (XXXI) is prepared by treatment of chloromalondialdehyde (XXIX) with isopropanol, yielding the ether (XXXII) and followed by reaction with ammoniun hydroxide.
Cyclization of the lithium enolate of ketosulfone (XXIV) with 2,3-dichloroacrolein (XXXIII) -- obtained by treatment of chloromalondialdehyde (XXIX) with oxalyl chloride and DMF in toluene -- followed by reaction with ammonium acetate or anhydrous ammonia.
Reaction of ketosulfone (XXIV) with 2-chloro-1,3-bis(dimethylamino)trimethinium hexaflourophosphate salt (XXXIV) in the presence of an equimolar amount of t-BuOK followed by treatment with HOAc/TFA and then heating at reflux with an excess of ammonium hydroxide.
2-Chloro-1,3-bis(dimethylamino)trimethinium hexaflourophosphate salt (XXXIV) is obtained by reaction of chloroacetic acid (XXXV) with hot dimethylformamide (XXXVI) and POCl3, and then the reaction mixture is treated with 5N NaOH and hexafluorophosphoric acid in water.
【1】
Davies, I.W.; Marcoux, J.-F.; Wu, J.; et al.; An efficient preparation of vinamidinium hexafluorophosphate salts. J Org Chem 2000, 65, 15, 4571.
|
【2】
Castañer, R.M.; Silvestre, J.S.; Sorbera, L.A.; Castañer, J.; Etoricoxib. Drugs Fut 2001, 26, 4, 346.
|
【3】
Davies, I.W.; Marcoux, J.-F.; Corley, E.G.; et al.; A practical synthesis of a COX-2-specific inhibitor. J Org Chem 2000, 65, 25, 8415.
|
【4】
Rossen, K.; Robbins, M.A.; Corley, E.G.; Wu, J.; Davies, I.W.; Marcoux, J.-F.; Reider, P.J.; Pye, P.; Larsen, R.D.; Annulation of ketones with vinamidinium hexafluorophosphate salts: An efficient preparation of trisubstituted pyridines. Org Lett 2000, 2, 15, 2339. |
【5】
Corley, E.G.; Davies, I.W.; Larsen, R.D.; Rossen, K.; Pye, P.J. (Merck & Co., Inc.); Process for synthesizing COX-2 inhibitors. US 6040319; WO 9955830 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XXIV) |
45711 |
1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]-1-ethanone
|
|
C15H15NO3S |
详情 |
详情
|
(XXIX) |
45712 |
(E)-2-chloro-3-hydroxy-2-propenal
|
|
C3H3ClO2 |
详情 |
详情
|
(XXX) |
45714 |
(E)-3-anilino-2-chloro-2-propenal
|
|
C9H8ClNO |
详情 |
详情
|
(XXXI) |
45716 |
(E)-3-amino-2-chloro-2-propenal
|
|
C3H4ClNO |
详情 |
详情
|
(XXXII) |
45715 |
(E)-2-chloro-3-isopropoxy-2-propenal
|
|
C6H9ClO2 |
详情 |
详情
|
(XXXIII) |
45713 |
(E)-2,3-dichloro-2-propenal
|
|
C3H2Cl2O |
详情 |
详情
|
(XXXIV) |
45717 |
|
|
C7H14ClF6N2P |
详情 |
详情
|
(XXXV) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(XXXVI) |
33491 |
Dimethylformamide
|
68-12-2 |
C3H7NO |
详情 | 详情
|
(XXXVII) |
45718 |
N-[(E)-2-chloro-3-(dimethylamino)-2-propenylidene]-N-methylmethanaminium chloride
|
|
C7H14Cl2N2 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(V) The cyclization of methyl acetoacetate (I), 2-methoxybenzaldehyde (II) and thiourea (III) by means of HCl in refluxing ethanol gives the tetrahydropyrimidine (IV), which is finally cyclized with chloroacetic acid (V) and benzaldehyde (VI) by means of sodium acetate in a refluxing mixture of acetic acid and acetic anhydride.
【1】
Kelicen, P.; Ertan, M.; Demirdamar, R.; Krebs, B.; Tozkoparan, B.; Lage, M.; Condensed heterocyclic compounds: Synthesis and antiinflammatory activity of novel thiazolo[3,2-a]pyrimidines. Arch Pharm 1998, 331, 6, 201.
|
【2】
Assandri, A.; et al.; Pharmacokinetics of a new antihypertensive pyrrolyl pyridazinamine (MDL-899) in the rat and the dog. Arzneim-Forsch Drug Res 1985, 35, 2, 508.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11791 |
methyl 3-oxobutanoate; Methyl acetoacetate
|
105-45-3 |
C5H8O3 |
详情 | 详情
|
(II) |
12568 |
2-Methoxybenzaldehyde; o-Methoxybenzaldehyde
|
135-02-4 |
C8H8O2 |
详情 | 详情
|
(III) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(IV) |
27432 |
methyl 4-(2-methoxyphenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate
|
|
C14H16N2O3S |
详情 |
详情
|
(V) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(VI) |
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(I) Thiazolidinedione (III) was prepared by condensation of chloroacetic acid (I) with thiourea (II). Alkylation of the potassium salt of (III) with 4-methoxyphenacyl bromide (IV) furnished the 3-phenacyl thiazolidinedione (V). Finally, aldol condensation of (V) with flavone-6-carboxaldehyde (VI) in the presence of NaOAc in HOAc provided the title compound.
【1】
Altanlar, N.; Ayhan-Killergil, G.; Synthesis of 3-substituted phenacyl-5-[2-phenyl-4H-4-oxo-1-benzopyran-6-yl(methylenyl]thiazolidine-2,4-diones and evaluation of their antimicrobial activity. Arzneim-Forsch Drug Res 2000, 50, 2, 154.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(II) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(III) |
10883 |
1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione
|
2295-31-0 |
C3H3NO2S |
详情 | 详情
|
(IV) |
21991 |
2-Methoxyphenacyl bromide; 2-bromo-1-(4-methoxyphenyl)-1-ethanone
|
2632-13-5 |
C9H9BrO2 |
详情 | 详情
|
(V) |
50131 |
3-[2-(4-methoxyphenyl)-2-oxoethyl]-1,3-thiazolidine-2,4-dione
|
|
C12H11NO4S |
详情 |
详情
|
(VI) |
50132 |
4-oxo-2-phenyl-4H-chromene-6-carbaldehyde
|
|
C16H10O3 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(B) Compound can be prepared in two related ways:
1) The acylation of 2,6-dimethylaniline (I) with chloroacetyl chloride (II) in acetic acid gives omega-chloro-2,6-dimethylacetanilide (III), which is then condensed with disodium salt of iminodiacetic acid (IV) in refluxing ethanol-water.
2) The reaction of (III) with ammonia in ethanol gives omega-amino-2,6-dimethylacetanilide (V), which is finally treated with chloroacetic acid (A) and NaOH in refluxing 95% ethanol.
【1】
Castaner, J.; Blancafort, P.; Serradell, M.N.; Paton, D.M.; Lidofenin. Drugs Fut 1979, 4, 5, 342.
|
【2】
Callery, P.S.; et al.; Tissue distribution of technetium-99m and carbon-14 labeled N-(2,6-dimethylphenylcarbamoylmethyl)iminodiacetic acid. J Med Chem 1976, 19, 7, 962-964.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(I) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(II) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(III) |
24100 |
2-chloro-N-(2,6-dimethylphenyl)acetamide
|
2198-53-0 |
C10H12ClNO |
详情 | 详情
|
(IV) |
39492 |
2-[(carboxymethyl)amino]acetic acid
|
142-73-4 |
C4H7NO4 |
详情 | 详情
|
(V) |
39493 |
2-amino-N-(2,6-dimethylphenyl)acetamide
|
|
C10H14N2O |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(III) The reaction of 2'-O-(triethylsilyl)paclitaxel (I) with dimethyl sulfide (DMS) and Bz2O2 in acetonitrile gives the 7-O-(methylsulfanylmethyl) derivative (II), which is condensed with chloroacetic acid (III) by means of N-iodosuccinimide (NIS) and Ag-OTf in THF to yield the 7-O-(chloroacetoxymethyl) derivative (IV). The desilylation of (IV) by means of HCl in acetonitrile affords the intermediate (V), which is finally condensed with the secondary amine (VI) by means of NaI in acetone to provide the target hybrid molecule.
【1】
Long, B.H.; Vyas, D.M.; Fairchild, C.; Kadow, J.F.; Rose, W.C.; Johnston, K.; Wittman, M.D.; Lee, F.L.; Synthesis and antitumor activity of novel paclitaxel-chlorambucil hybrids. Bioorg Med Chem Lett 2001, 11, 6, 811.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
49369 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-([(2R,3S)-3-(benzoylamino)-3-phenyl-2-[(triethylsilyl)oxy]propanoyl]oxy)-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C53H65NO14Si |
详情 |
详情
|
(II) |
49370 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-([(2R,3S)-3-(benzoylamino)-3-phenyl-2-[(triethylsilyl)oxy]propanoyl]oxy)-1-hydroxy-10,14,17,17-tetramethyl-9-[(methylsulfanyl)methoxy]-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate |
|
C55H69NO14SSi |
详情 |
详情
|
(III) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(IV) |
49371 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-([(2R,3S)-3-(benzoylamino)-3-phenyl-2-[(triethylsilyl)oxy]propanoyl]oxy)-9-[[(2-chloroacetyl)oxy]methoxy]-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate |
|
C56H68ClNO16Si |
详情 |
详情
|
(V) |
49372 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy]-9-[[(2-chloroacetyl)oxy]methoxy]-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate |
|
C50H54ClNO16 |
详情 |
详情
|
(VI) |
49373 |
2-([2-[(4-[4-[bis(2-chloroethyl)amino]phenyl]butanoyl)oxy]ethyl]amino)ethyl 4-[4-[bis(2-chloroethyl)amino]phenyl]butanoate
|
|
C32H45Cl4N3O4 |
详情 |
详情
|